Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism

Diabetes Care

Volumn 14, Issue 3, 1991, Pages 203-209

  Lithell, Hans O L ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; DILTIAZEM; GLUCOSE; INSULIN; LIPID; METOPROLOL; PINDOLOL; PRAZOSIN; PROPRANOLOL;

BLOOD PRESSURE; CONTROLLED STUDY; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; LIPID METABOLISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW;

ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; CAPTOPRIL; DOUBLE-BLIND METHOD; GLUCOSE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; META-ANALYSIS; METOPROLOL; PINDOLOL; PROPRANOLOL; PROSPECTIVE STUDIES;

EID: 0025974696     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.14.3.203     Document Type: Article

References (35)

1. Sicree RA, Zimmet PZ, King HOM, Coventry JS: Plasma insulin response among Nauruans: prediction of deterioration of glucose tolerance over 6 yr. Diabetes 36:179-86, 1987
2. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500-506, 1988
3. Medical Research Council Working Party on Mild to Moderate Hypertension: Adverse reactions to bendroflu-azide and propranolol for the treatment of mild hypertension. Lancet 2:539-43, 1981
4. Amery A, Berthaux P, Bulpitt C, Deruyttere M, de Schaepdryver A, Dollery C, Fagard R, Forette F, Hellemans J, Lund-Johansen P, Mutsers A, Tuomilehto J: Glucose intolerance during diuretic therapy: results of trial by the European Working Party on high blood pressure in the elderly. Lancet 1:681-83, 1978
5. Murphy MB, Lewis PJ, Kohner E, Schumer B, Dollery CT: Glucose intolerance in hypertensive patients treated with diuretics: a fourteen year follow-up. Lancet 2:1293-95, 1982
6. Bengtsson C, Blohmé G, Lapidus L, Lindquist O, Lundgren H, Nyström E, Peterson K, Sigurdsson JA: Do antihypertensive drugs precipitate diabetes? Br Med J 289:1495-97, 1984
7. Skarfors ET, Lithell HO, Selinus I, Åberg H: Do antihypertensive drugs precipitate diabetes in predisposed men? Br Med J 298:1147-52, 1989
8. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:214-23, 1979
9. Pollare T, Lithell H, Selinus I, Berne C: Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 31:415-20, 1988
10. 1c, by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 32:1867-72, 1986
11. Pollare T, Lithell H, Selinus I, Berne C: Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br Med J 297:1152-47, 1989
12. Pollare T, Lithell H, Mörlin C, Präntare H, Hvarfner A, Ljunghall S: Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens 7:551-59, 1989
13. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321:868-73, 1989
14. Lithell HO, Pollare T, Berne C: Insulin sensitivity in newly detected hypertensive patients: influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters. J Cardiovasc Pharmacol 15 (Suppl. 5):S46-52, 1990
15. Jauch K-W, Hartl W, Guenther B, Wicklmayr M, Rett K, Dietze G: Captopril enhances insulin responsiveness of forearm muscle tissue on non-insulin-dependent diabetes mellitus. Eur J Clin Invest 17:448-54, 1987
16. Iimura O, Shimamoto K, Tanaka S, Hosada S, Nishitani T, Ando T, Masucla A: The mechanism of the hypotensive effect of captopril (converting enzyme inhibitor) with spe cial reference to the kallikrein-kinin and renin-angiotensin systems. Jpn J Med 25:34-39, 1986
17. Ames RP: The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs. Drugs 32:335-57, 1986
18. Bengtsson C, Blohmé G, Lapidus L, Lundgren H: Diabetes in hypertensive women: an effect of antihypertensive drugs or the hypertensive state per se? Diabetic Med 5:261-64, 1988
19. Swislocki ALM, Hoffman BB, Reaven GM: Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 2:419-23, 1989
20. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH: Blood pressure, stroke, and coronary heart disease. II. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1:827-38, 1990
21. Holme I: Treatment for mild hypertension (Abstract). Tidsskr Nor Laegeforen 108:1932-36, 1988
22. Pyörälä K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2:131-41, 1979
23. Ducimetière P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle aged population. Diabetologia 19:205-10, 1990
24. Welborn TA, Wearne K: Coronary heart disease indicence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:154-60, 1979
25. Stout RW: Insulin and atheroma - an update. Lancet 1:1077-79, 1987
26. Larrett RJ, McCartney P, Keen H: Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22:79-84, 1982
27. Efendić S, Wajngot A, Cerasi E, Luft R: Insulin release, insulin sensitivity, and glucose intolerance. Proc Natl Acad Sci USA 77:7425-29, 1980
28. DeFronzo R: The effect of insulin on renal sodium metabolism. Diabetologia 21:165-71, 1981
29. Landsberg L: Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 236:1081-90, 1986
30. Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetière P, Claude JR: Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? Am J Epidemiol 124:624-32, 1986
31. Castelli WP: The triglyceride issue: a view from Framingham. Am Heart J 112:432-37, 1986
32. May GS: A review of long-term beta-blocker trials in survivors of myocardial infarction. Circulation 67 (Suppl. 1):146-49, 1983
33. 1988 Joint National Committee: The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 148:1023-38, 1988
34. Guidelines Sub-Committee of the WHO/ISH Mild Hypertension Liason Committee: 1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH Meeting. J Hypertens 7:689-93, 1989
35. Pollare T, Lithell H, Berne C: Insulin resistance is a char-acteristic feature of primary hypertension independent of obesity. Metabolism 39:167-74, 1990